Discover What DNA Reveals About Your Breast Health
Update: WholeMe will be closing registration for new participants on December 16th.
The next phase of WholeMe genomic testing is here to help women feel informed about their breast cancer risk. AdventHealth will be partnering with Helix, a population genomics company, and Sema4, a patient-centered health intelligence company, to deliver more comprehensive breast cancer DNA test results.
This new study will enroll participants as they are scheduling their annual mammography appointments (at a participating site) and provide a breast cancer risk assessment to all participants.
If you choose to participate, your assessment will be given before your mammogram appointment.
- Those at high risk will receive a clinical referral to an AdventHealth high-risk clinic and no further study activities are required.
- Those at low/average risk would have no further study activities.
- Those at moderate risk will be asked to provide a saliva sample for genetic testing during their mammogram appointment.
Partnering for More Health Insights
We're excited to inform you that the AdventHealth WholeMe research study is evolving! In this new chapter, AdventHealth will be partnering with Sema4, a patient-centered health intelligence company, to deliver even more comprehensive DNA test results.
As part of your WholeMe participation and consent, interpretations for breast and ovarian cancers will be completed. A full list of genes can be found below.
You'll have access to a care navigator who will assist you with the next steps. If you have a positive result in one of the genes being tested, you may be asked to complete a series of follow-up appointments, including:
- A confirmatory genetic test with Sema4: a new saliva kit will be sent directly to your home with instructions for providing your sample and mailing it back.
- A genetic counseling session with Sema4: this can be scheduled directly with Sema4 through their patient portal and is done as a virtual visit.
- An appointment with one of AdventHealth's medical geneticists: a care navigator will assist with scheduling this follow-up appointment.
We recommend creating an AdventHealth account so you can access your results as soon as they are available. You can register for an account here.
If you have any questions, please reach out to the WholeMe Research team via email at [email protected].
Whole Me Breast Cancer Genes
Upcoming Study Sites
The WholeMe study will be enrolling potential participants who schedule at the following locations:
Dates for Enrollment
May 1 – June 29, 2022
AdventHealth Imaging Center Princeton, AdventHealth Winter Park
July 1 – August 31, 2022
AdventHealth Imaging Center Lake Mary, AdventHealth Apopka
September 1 – October 31, 2022
AdventHealth Imaging Center Winter Garden, AdventHealth Celebration
November 1 – December 31, 2022
AdventHealth Imaging Center Princeton, AdventHealth Kissimmee
If you’re interested in enrolling in WholeMe, click below to complete the form and our study team will be in touch.
Breast Cancer Resources
Frequently Asked Questions
- What is the WholeMe breast cancer study?
- What if a participant doesn’t have moderate risk?
- Why are we doing this?
- What are we evaluating?
- Who can join the study?
- What’s breast cancer?
- If I have breast cancer, could I pass this on to my children?
- What about men who have genetic markers for breast cancer?
- If I have breast cancer, can I be kicked off my health insurance, life insurance, or not be approved for either in the future?
- If I have breast cancer, can my children be denied medical or insurance coverage?
- Is this information incorporated into my medical record?
- How long will the study last?
- Is there any cost to the consumer?
- What is a consent form? Why is it necessary?
- Can I choose to participate in the study?
- Who has access to my information?
- How is my information protected?
- What if I change my mind and want to withdraw?
- What if I have general research questions about this research study?